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INTRODUCTION
T lymphocytes are sentinels of the adaptive immune system tailored to identify and eliminate threats to the host. In response to antigen-specific and inflammatory signals, naive T cells transition to an activated state marked by rapid growth and proliferation, resulting in the generation of a T effector (Teff) cell pool sufficient to mediate protective immunity. One of the fundamental programs triggered by T cell receptor (TCR) activation is the reprogramming of cellular metabolism to support the demands of Teff cell expansion Wang and Green, 2012) . This metabolic shift is characterized by increased expression of nutrient transporters and glycolytic enzymes early after activation (Macintyre et al., 2014; Wang et al., 2011) . Glycolytic flux provides energy and building blocks for T cell expansion, but also influences effector function by regulating cytokine production by Teff and T memory (Tmem) cells (Cham and Gajewski, 2005; Chang et al., 2013; Gubser et al., 2013) . The requirement of specific nutrients to support T cell function raises the possibility that the metabolic microenvironment and nutrient availability can impact immunity by influencing T cell function.
One pathway that has emerged as a key metabolic node in proliferating cells is one-carbon metabolism, which encompasses a network of interconnected biochemical pathways that facilitate the transfer of one-carbon units for biosynthesis (Locasale, 2013) (Figure 1A) . Folate intermediates such as tetrahydrofolate (THF) are active carriers of one-carbon units used for de novo nucleotide synthesis. Connected to the folate cycle is the methionine cycle, which is involved in the synthesis of amino acids, lipids, and S-adenosyl methionine (SAM), the latter serving as the primary methyl donor for cellular methylation reactions. The methionine cycle is linked to the trans-sulphuration pathway, which produces glutathione, an important cellular antioxidant. Therapeutics that disrupt folate metabolism such as methotrexate are used to treat certain autoimmune conditions, including rheumatoid arthritis and Crohn's disease (Cesarini et al., 2016; Cronstein, 1996) , highlighting the clinical importance of one-carbon metabolism to immune cell function.
While THF and its derivatives function as carriers of methyl groups during one-carbon metabolism, one of the major carbon donors to the pathway is the non-essential amino acid serine. Serine is converted to glycine by the enzyme serine hydroxymethyl transferase (Shmt), which transfers a methyl group from serine to THF, thus helping to drive the folate cycle ( Figure 1A ). Serine can be taken up by cells from exogenous sources or synthesized de novo from the glycolytic intermediate 3-phosphoglycerate (3-PG) (Pearce et al., 2013) . How serine is sourced for cellular biosynthesis varies widely among proliferating cells.
Many cancer cells are highly dependent on exogenous serine for biosynthesis (Labuschagne et al., 2014; Maddocks et al., 2013) , while others increase de novo serine biosynthesis from glucose to drive growth (Locasale et al., 2011; Possemato et al., 2011) . Collectively, the serine, glycine, one-carbon (SGOC) metabolic network helps coordinate nucleotide, NADPH, and glutathione biosynthesis to support macromolecular biosynthesis and redox balance in cancer cells (Mehrmohamadi et al., 2014) .
In this study, we investigated the dynamics of SGOC metabolism and serine availability on T cell function. We report that serine is an essential metabolite for optimal T cell expansion following antigenic stimulation. T cells cultured without exogenous serine or with Shmt inhibition show no impairment in activation, bioenergetics, or cytokine production, but fail to proliferate efficiently. Strikingly, these results translate in vivo, as antigenspecific T cell expansion is impaired in animals maintained on white) or stimulated with anti-CD3/CD28 antibodies for 48 hr (aCD3/28, black). Specific transcript levels were determined relative to HK1 mRNA levels and normalized to unstimulated CD8 + T cells (mean ± SEM, n = 3).
(D) Immunoblot of Phgdh, Psat, Shmt1, and Shmt2 protein levels in naive and activated T cells. Mouse T cells were left unstimulated (naive) or stimulated with anti-CD3 and -CD28 (aCD3/28) antibodies for 48 hr prior to protein extraction. (E) Expression of SGOC metabolism genes in activated human T cells as determined by qPCR. Human CD8 + T cells were left unstimulated (À) or activated with anti-CD3/CD28 coated beads (+) for 48 hr. Transcript levels for the indicated genes were determined relative to 18 s mRNA levels and normalized to unstimulated control cells (mean ± SEM, n = 5). *p < 0.05; **p < 0.001; ***p < 0.0001. a serine-restricted diet. Our data implicate serine metabolism as an intrinsic regulator of T cell proliferative capacity-independent of glycolysis-that is required for optimal T cell responses in vivo.
RESULTS
The SGOC Network Is a Metabolic Hallmark of Proliferating T Cells Recent work has identified the SGOC metabolic network as a metabolic feature of many cancer cells (Mehrmohamadi et al., 2014) ( Figure 1A ). To better understand the dynamics of SGOC metabolism during T cell responses in vivo, we analyzed the expression of a subset of SGOC network genes in CD8 + TCRtransgenic OT-I T cells (specific for OVA 257-264 ) responding to OVA-expressing Listeria monocytogenes (LmOVA) infection in vivo, as previously generated by the Immunological Genome Project (Best et al., 2013 ) ( Figure 1B ). We observed a clustering of SGOC network gene products increased in early CD8 + Teff cells (0.5-2 days post-infection [dpi], correlating with the stage of rapid Teff cell expansion following infection). These included genes involved in de novo serine biosynthesis (Psat1, Phgdh, and Psph), the THF cycle (both mitochondrial [Mthfd2 and Mthfd1l] and cytosolic [Mthfd1]), and the methionine cycle (Mat2a, Mtrr, and Mtr). The largest increase was observed in Shmt1 and Shmt2 expression ( Figure 1B) , which regulates the entry of serine-dependent carbon into the cytosolic and mitochondrial THF cycles, respectively. Heightened expression of these genes was largely restricted to early Teff cells, with expression returning to baseline levels (as observed in naive CD8 + T cells) by 6 dpi ( Figure 1B) . The exception to this trend was the expression of Tyms and Dhfr, which together mediate a shunt of the THF cycle involved in thymidine biosynthesis ( Figure 1A ) that remained increased in Teff cells at 6 dpi.
We next verified the expression of SGOC network components in mouse and human T cells by qPCR. Expression of mRNA transcripts for the serine biosynthesis pathway (Phgdh, Psat, and Psph), serine entry into one-carbon metabolism (Shmt1 and Shmt2), and thymidine biosynthesis (Dhfr and Tyms) was induced in both CD8 + ( Figure 1C ) and CD4 + T cells ( Figure S1A , available online) upon stimulation with anti-CD3 and anti-CD28 antibodies. We observed a corresponding increase in protein expression of several of these enzymes upon T cell activation ( Figure 1D ). Activated human T cells also displayed a broad upregulation of genes involved in serine biosynthesis and both the cytosolic and mitochondrial THF pathways ( Figures 1E and S1B ). Of note, expression of Mthfd2, an mTORC1-responsive enzyme of the mitochondrial THF cycle that mediates production of 10-formyl-THF for de novo purine biosynthesis (Ben-Sahra et al., 2016) , was induced by TCR stimulation in both mouse and human CD8 + T cells (Figures 1C and 1E) . These data confirm upregulation of the SGOC metabolic network as a hallmark of activated Teff cells in vitro and in vivo, both in mouse and human.
Teff Cells Derive the Majority of Their Serine from Extracellular Sources
We next assessed the dynamics of serine metabolism in Teff cells using stable isotope tracer analysis (SITA). We first cultured proliferating mouse and human Teff cells with U-[
13 C]-glucose and examined the steady-state incorporation of 13 C-glucosederived carbon into serine and glycine using gas chromatography-mass spectrometry (GC-MS). Approximately 30% of the intracellular serine pool was labeled from glucose in mouse Teff cells, with $20% of serine carbon being fully labeled (m+3) (Figure 2A) . Glucose-dependent labeling of serine was lower in activated human CD8 + T cells, constituting $20% of the intracellular serine pool ( Figure 2B ). Partially labeled serine isotopomers (m+1 and m+2) were also detected, likely due to the inter-conversion of 13 C-labeled and unlabeled serine and glycine, indicating the bi-directional nature of this metabolic pathway.
The majority of intracellular serine did not contain carbon from 13 C-glucose (m+0), suggesting additional routes for serine entry into one-carbon metabolism in Teff cells. We next assessed the contribution of extracellular serine to SGOC metabolism in T cells by culturing activated Teff cells with U-[
13 C]-serine.
Rapid extracellular serine uptake was observed in Teff cells, with $75% of the intracellular serine pool labeled as 13 C-serine (m+3) and reaching steady state within 15 min of culture (Figure 2C) . These data suggest that most of the intracellular serine pool in Teff cells comes from the extracellular environment. However, carbon from both 13 C-glucose-derived serine (Figures 2A  and 2B ) and U-[
13 C]-serine ( Figure 2C ) was readily metabolized into 13 C-glycine (m+2), indicating that serine from both de novo biosynthesis and extracellular sources contributed to the onecarbon pool in Teff cells.
THF moves one-carbon units through various oxidation states using a series of connected enzymatic redox reactions. N 5 -N 10 -methyl-THF conversion to N 10 -formyl-THF by Mthfd1 or Mthfd2 is used for purine nucleotide synthesis. One-carbon units in the THF pool can also be used to generate deoxythymidine monophosphate (dTMP) or to synthesize methionine ( Figure 1A ). SITA using U-[ 13 C]-glucose or U-[ 13 C]-serine revealed no labeling of methionine from these carbon sources ( Figure 2D ). These data indicated that one-carbon units from either de novo synthesized serine or extracellular serine contributed to the THF cycle, but did not continue into the methionine cycle.
Dietary Serine Availability Dictates T Cell Responses In Vivo
Given that most of the intracellular serine in activated T cells was taken up from the extracellular environment (Figure 2 ), we questioned whether extracellular serine availability could impact T cell responses in vivo. To test this, we maintained mice for 2 weeks on a diet lacking serine and glycine to decrease circulating levels of these amino acids. Since serine and glycine are non-essential amino acids, removal of these nutrients from the rodent diet is well tolerated in vivo (Maddocks et al., 2013) . Compared to control animals, mice maintained on the serine/glycine-free diet for 2-4 weeks displayed reduced levels of serine and glycine in their blood, while the abundance of other amino acids was not affected (Table S1 ). Compared to animals fed a control diet containing serine and glycine, analysis of immune cell numbers from the spleens of animals fed serine/glycine-free chow for 2 or 4 weeks revealed no significant change in numbers of lymphocytes ( (Table S2 ).
We next examined T cell responses to LmOVA infection in a low serine/glycine environment in vivo. Congenic CD45.1 + mice were maintained on a control or serine/glycine-free diet for 2 weeks prior to adoptive transfer of naive CD45.2 + OT-I CD8 + T cells, and then infected 1 day later with a modified attenuated strain of LmOVA ( Figure 3A ). At 7 dpi, splenocytes from infected mice were analyzed for the expansion of OVA-specific CD45.2 + T cells by flow cytometry. We observed a significant reduction in both the percentage and number of OVA-specific CD8 + CD45.2 + T cells in mice maintained on the serine-restricted feed ( Figure 3B ), corresponding to an $70% reduction in responding antigen-specific CD8 + T cells in these mice. This translated into an overall reduction in the number of IFN-g-and TNFa-producing effector CD8 + T cells following re-stimulation with OVA 257 peptide (SIINFEKL) ex vivo (Figures S2A and S2B) . Serine restriction did not affect overall numbers of bystander CD8 + ( Figure S2C ) and CD4 + ( Figure S2D ) T cells following
LmOVA infection, consistent with our previous observation that overall immune cell numbers were not affected by the serine/ glycine-free feed (Table S2) . Next, we examined the effect of serine restriction on endogenous T cell responses to Listeria infection. C57BL/6 mice maintained on control or serine/glycine-free feed for 2 weeks were infected with LmOVA, and endogenous CD8 + and CD4 + T cell responses were assessed 7 days later ( Figure 3C ). Similar to Figure 3B , the percentage and number of endogenous OVA-specific CD8 + T cells were significantly reduced in animals maintained on the serine-restricted diet 7 dpi, compared to animals on the control diet ( Figure 3D ). Analysis of splenocytes ex vivo following re-stimulation with OVA 257 peptide revealed over a 50% reduction in both the number and percentage of IFN-g-producing CD8 + T cells for animals maintained on the serine-restricted diet ( Figure 3E ). The number of IFN-g-producing CD4 + Th1 cells responding to LLO 190 peptide stimulation was similarly reduced in mice fed the serine/glycine-free chow ( Figure S2E ), indicating that antigen-specific CD4 + T cell responses were similarly affected by serine restriction in vivo. Interestingly, the quantity of cytokine produced on a per-cell basis by CD8 + and CD4 + Teff cells responding to LmOVA, as determined by the mean fluorescence intensity (MFI) of the IFN-g + cell population, was not affected by diet, suggesting that dietary serine restriction did not affect the functionality of the T cells that could respond to infection (Figures 3F and S2F) . Analysis of overall CD8 + and CD4 + T cell numbers in infected mice revealed no difference in total T cell numbers ( Figure S2G ). Collectively, these data indicated that dietary serine restriction could impact antigen-specific T cell expansion in vivo.
One consequence of impaired expansion of Teff cells is a reduced memory T cell pool and reduced T cell responses and pathogen clearance upon re-challenge (Harty and Badovinac, 2008) . To assess whether serine availability during T cell priming affects protective immunity, we maintained C57BL/6 mice on control or serine/glycine-free feed for the duration of the primary LmOVA response (7 dpi), after which all mice were switched to the control feed containing serine and glycine for an additional 25 days ( Figure 3G ). Tracking OVA-specific CD8 + T cells in the peripheral blood of mice over the course of the immune response to LmOVA infection revealed similar contraction of OVA-specific (legend continued on next page) CD8 + T cells between immunized mice maintained on the control or serine/glycine-free diet for the first 7 days of the infection (Figure S2H) . Mice fed the control diet for the entire duration of the experiment displayed a slightly higher percentage of circulating memory OVA-specific CD8 + T cells at 21 dpi compared to mice fed a serine-free diet for the first 7 days of infection ( Figure S2H ). Mice were then re-challenged with a lethal dose of virulent LmOVA at 32 dpi under serine-replete conditions ( Figure 3G ). Analysis of serine and glycine abundance in the blood prior to secondary challenge revealed no difference in serine and glycine levels in animals initially maintained on the serine/glycine-free feed relative to controls ( Figure S2I ). Despite having normal blood serine/glycine levels, mice primed under serine/glycinefree conditions displayed reduced secondary T cell responses to virulent LmOVA, exhibiting reduced numbers of OVA-specific ( Figure 3H ) and IFN-g-producing ( Figure 3I ) CD8 + T cells 5 days post-re-challenge. This impaired secondary T cell response corresponded to a decrease in bacterial clearance in mice originally immunized under serine/glycine-free conditions (Figures 3J and S2J) . These data confirmed that serine availability during immunization could impact T cell-mediated immunity in vivo.
Serine Is Required for Teff Cell Proliferation but Is Dispensable for Effector Function and Bioenergetics
We next investigated why serine was essential for antigen-specific T cell expansion in vivo. We first assessed the impact of serine availability on the proliferation of T cells from C57BL/6 mice in vitro following polyclonal activation with anti-CD3 and anti-CD28 antibodies. Total T cell proliferation measured by thymidine incorporation ( Figure 4A ) or the proliferation of CD4 + or CD8 + T cells by dye dilution assay ( Figure 4B ) revealed clear reductions in T cell proliferation when stimulated in medium containing glucose and glutamine but lacking serine and glycine. Human CD8 + T cells displayed similar reductions in TCR-stimulated proliferation when deprived of serine and glycine ( Figure S3A ).
To assess whether serine was required for the continued proliferation of activated T cells, we expanded T cells in complete medium for 2 days, then continued culture in complete medium or switched the cells to medium lacking serine and glycine. Teff cells cultured without serine and glycine displayed reduced proliferation ( Figure 4C ) but remained viable ( Figure S3B ). Despite displaying reduced proliferation, T cells cultured under serinefree conditions displayed comparable expression of activation markers (CD69, CD25, and CD44) ( Figure 4D ) and continued to produce IFN-g at similar levels to T cells grown under full serine conditions ( Figure 4E ). Thus, serine availability affected T cell proliferative capacity without impacting their ability to become activated or acquire effector functions.
One possibility for the reduced expansion of antigen-specific T cells under serine-free conditions in vivo is that serine availability affects the stimulatory capacity of antigen-presenting cells (APCs) such as dendritic cells (DCs). DCs activated with LPS under serine/glycine-free conditions showed comparable surface expression of activation markers (CD86 and CD40) ( Figure S3C ) and secreted cytokines (TNF-a and IL-12p40) at similar levels to DCs activated under full medium conditions ( Figure S3D ), indicating that serine limitation did not affect the stimulatory capacity of APCs in vitro.
T cell bioenergetics can also be a regulator of T cell proliferative capacity. Inhibiting mitochondrial OXPHOS or limiting the glycolytic capacity of T cells has been shown to suppress T cell proliferation Macintyre et al., 2014) . We measured the extracellular acidification rate (ECAR, a readout of glycolysis) and oxygen consumption rate (OCR, a measure of OXPHOS) (Blagih et al., 2015) of Teff cells cultured with or without serine and glycine, and found no impact of serine availability on T cell bioenergetics ( Figure 4F ). Analysis of culture medium revealed similar glucose and glutamine consumption rates between serine-starved and control Teff cells ( Figure S3E ). Teff cells readily metabolized glucose to lactate ( 13 C-Glc/lactate (m+3)) and the TCA cycle intermediate citrate ( 13 C-Glc/citrate (m+2)) regardless of serine and glycine availability ( Figure 4G ). These data indicated that SGOC metabolism was functioning independently of glucose utilization and cellular bioenergetics in Teff cells yet was required for T cell proliferation even when glucose was abundant.
Serine Entry into One-Carbon Metabolism Is a Checkpoint for T Cell Proliferation
We next assessed whether the decrease in T cell proliferation triggered by serine limitation was due to the reduced flux of serine into the one-carbon metabolism pathway. We used a dual Shmt inhibitor (RZ-2994) with high specificity to both Shmt1 and Shmt2 to block serine metabolism to glycine in T cells ( Figure 5A ). RZ-2994 was identified from a series of pyrazolopyrans active against plant and Plasmodium SHMTs and optimized for activity against human SMHT1 and SHMT2 (Witschel et al., 2015) . We verified that RZ-2994 could inhibit both Shmt enzymes in vitro, with an IC 50 of 5 and 13 nM for Shmt1 and Shmt2, respectively ( Figure 5B point of activation ( Figure 5E ) or to actively proliferating T cell cultures ( Figure 5F ). RZ-2994 lowered T cell proliferation in a dose-dependent manner regardless of the presence of serine or glycine in the culture medium ( Figure S4A ). Interestingly, RZ-2994 had minimal effects on T cell viability, even at higher drug concentrations that induced maximal inhibition of T cell proliferation (>2.5 mM) ( Figure S4B ). We chose 1.25 mM as the concentration of RZ-2994 used for all subsequent experiments, as this was the EC 50 dose for inhibiting cell proliferation that did not significantly affect T cell viability ( Figure 5G ). Similar to Teff cells cultured in the absence of serine and glycine, T cells cultured with RZ-2994 displayed no changes in the expression of activation markers (CD25 and CD44) ( Figure S4C ). Furthermore, RZ-2994 did not alter the metabolism of glucose by T cells, as the conversion of U-[ 13 C]-glucose to lactate or citrate was unaffected by RZ-2994 treatment ( Figure 5H ).
Extracellular Serine Contributes to Purine Nucleotide Synthesis in Teff Cells
Given that T cell bioenergetics were unaffected by serine availability, we hypothesized that SGOC-mediated biosynthesis may run in parallel to glycolysis to control Teff cell proliferation. Input of serine-derived carbon into the THF cycle yields one-car- bon units as well as glycine, both critical for de novo purine nucleotide synthesis ( Figure 6A ) (Labuschagne et al., 2014) .
Following culture of proliferating Teff cells with U-[
13 C]-serine, we found that purine nucleotides (ATP and GTP) were readily labeled from 13 C-serine (between 75% and 85% of the total metabolite pools), while pyrimidines (UTP and CTP) contained no carbon from serine ( Figure 6B ).
De novo synthesis of purine rings incorporates two carbons from glycine and two one-carbon units from the THF cycle ( Figure 6A ). U-[ 13 C]-serine can contribute up to a total of four 13 C-carbons in a single purine nucleotide: a single 13 C-carbon unit from the THF cycle (m+1); incorporation of 13 C-glycine or two 13 C-carbon units from the THF cycle (m+2); incorporation of 13 C-glycine and one 13 C-carbon unit (m+3); or incorporation of 13 C-glycine and two 13 C-carbon units, all generated from U-[
13 C]-serine (m+4). Analysis of the mass isotopomer distribution (MID) in purine nucleotides from Teff cells cultured with U-[ 13 C]-serine revealed a roughly equal distribution of all 13 C labeling patterns (m+1 through m+4) in IMP, the upstream precursor for ATP and GTP biosynthesis ( Figure 6C ). Guanosine (GMP, GDP, and GTP) and adenosine (AMP, ADP, and ATP) nucleotides displayed similar labeling patterns to IMP ( Figure 6C ). The presence of partially labeled purine nucleotides (m+1 through m+3) suggested that other unlabeled sources of glycine and one-carbon units could contribute to de novo purine biosynthesis in T cells. However, the presence of fully labeled (m+4) purine nucleotides from U-[
13 C]-serine indicated that exogenous serine could contribute all the one-carbon and glycine components required for purine biosynthesis in proliferating Teff cells.
Culturing Teff cells with RZ-2994 at doses that affected T cell proliferation, but not cell viability ( Figures S4A and S4B) , reduced the abundance of U-[
13 C]-serine-derived GTP and ATP (Figure 6D) . Analysis of the MID for purine nucleotides from RZ-2994-treated Teff cells indicated that Shmt inhibition particularly impacted the formation of highly labeled purine rings (m+3 and m+4) ( Figure 6E ). These data indicate that sufficient Shmt activity is required to source sufficient one-carbon units and glycine to complete purine biosynthesis.
Serine-Dependent Nucleotide Biosynthesis Is Required for Optimal T Cell Proliferation
To test whether the inability of serine-starved T cells to proliferate was due to insufficient SGOC-dependent purine biosynthesis, we provided serine-starved T cells with formate, a one-carbon metabolite used in the THF cycle to produce N 10 -formyl THF, the one-carbon donor for purine nucleotide biosynthesis (Figure 1A) . Formate can function to replenish the one-carbon pool in the absence of serine (Labuschagne et al., 2014) . Providing T cells with formate and glycine was sufficient to support the optimal proliferation of naive T cells in medium lacking serine ( Figure 7A) . Similarly, serine-starved Teff cells displayed similar proliferation to control cells if supplied with exogenous formate and glycine ( Figure 7B ). Formate alone was unable to rescue the proliferation of Teff cells cultured without serine and glycine ( Figure 7B ), as there was no glycine available to complete de novo purine biosynthesis. Addition of glycine alone had an inhibitory effect on Teff cell proliferation ( Figure 7B ), likely due to Shmt-mediated conversation of glycine to serine resulting from low intracellular serine levels, leading to depletion of the one-carbon pool (Labuschagne et al., 2014) . As an alternative approach, supplementing T cell cultures with deoxynucleotides (dNTPs) enhanced the proliferation of T cells growing in both control and serine/glycine-free conditions ( Figure 7C ). Culturing T cells with the Shmt inhibitor RZ-2994 reduced T cell proliferation further than serine and glycine deprivation alone ( Figure 7D ), likely due to its ability to block the formation of N 5 -N 10 -methylene-THF from both exogenous and glucose-derived serine. However, providing T cells with formate and glycine reversed the anti-proliferative effects of RZ-2994 on T cell proliferation ( Figure 7D ). Collectively, these data indicated that serine metabolism was essential for optimal T cell proliferation through its contribution to nucleotide biosynthesis.
DISCUSSION
Reprogramming of T cell metabolism following antigenic stimulation is important for effective T cell-mediated immunity. Glucose is a key metabolic substrate involved in this process, fueling both T cell bioenergetics and biosynthesis required for growth and the development and maintenance of effector func- tions (Cham and Gajewski, 2005; Chang et al., 2013; Jacobs et al., 2008; Macintyre et al., 2014) , as well as glutamine, which supports mitochondrial bioenergetics (Blagih et al., 2015 ). Here we demonstrate that serine is an essential metabolite for T cell effector responses that regulates clonal T cell expansion through its support of one-carbon metabolism, independent of glucose. We show that extracellular serine supplies proliferating T cells with the necessary biosynthetic precursors-glycine and one-carbon units-for the de novo production of purine nucleotides. Regulating this process are the metabolic enzymes Shmt1 and Shmt2, which, by controlling carbon entry into the one-carbon metabolism pathway, act as a biosynthetic checkpoint for T cell proliferation. This pathway runs parallel to glycolysis, with serine metabolism affecting T cell proliferation without impacting bioenergetics or effector function. Our data implicate serine as an immunomodulator that can shape adaptive immunity through its influence on T cell proliferative capacity.
T cell activation is associated with increases in aerobic glycolysis and OXPHOS that help support the proliferation and function of differentiated effector cells (Wang and Green, 2012) . OXPHOS is required for T cell activation and early expansion (1-2 days post-activation) Sena et al., 2013) , while aerobic glycolysis supports T cell effector function, in part by regulating cytokine mRNA translation and mTORC1 activity (Blagih et al., 2015; Chang et al., 2013) . Genes involved in SGOC metabolism are upregulated concomitantly with glycolysis in activated T cells, and their expression is largely restricted to early Teff cells undergoing rapid proliferation following antigenic encounter. However, serine is effectively uncoupled from T cell bioenergetics. Instead, our data show that serine availability influences T cell proliferation by determining the quantity of one-carbon intermediates available for cellular biosynthesis, similar to how limiting the production of biosynthetic intermediates such as citrate (Griss et al., 2015; Hatzivassiliou et al., 2005) and aspartate (Birsoy et al., 2015; Sullivan et al., 2015) can impact cell proliferation. In support of this model, providing T cells with glycine and one-carbon units from formate is sufficient to bypass the impact of serine starvation or Shmt inhibition on T cell proliferation. These data suggest a bifurcation of metabolic activities in Teff cells, with glucose fueling cellular bioenergetics and effector function and SGOC metabolism functioning as a metabolic checkpoint for nucleotide biosynthesis that controls T cell expansion.
Maintaining ample flux of one-carbon units to the THF cycle is a prominent feature of transformed cells, which rely either on exogenous serine or de novo synthesis from glucose to maintain tumor growth (Locasale et al., 2011; Maddocks et al., 2013; Mehrmohamadi et al., 2014; Possemato et al., 2011) . Our data indicated that Teff cells source serine from both pathways, and that the production of 13 C-glycine from either glucose-derived or extracellular serine is comparable. Several major points stand out from these data. First, despite the existence of nucleotide salvage pathways, most nucleotides in Teff cells contain purine rings generated from de novo biosynthesis. Shmt is a key regulatory point for this pathway, as blocking Shmt activity inhibits T cell proliferation even in glucose-replete conditions. These data are consistent with recent work demonstrating that Shmt isoforms may functionally compensate for each other in T cells (Ron-Harel et al., 2016) . Second, the sensitivity of Teff cell proliferation to serine deprivation indicates that de novo serine biosynthesis may not be sufficient to generate the serine required for optimal Teff cell proliferation, nor are other inputs (i.e., glycine and methionine) able to compensate when serine is limiting. While glycine can potentially donate one-carbon units into the THF cycle through the glycine cleavage system, glycine cannot compensate for serine deficiency in T cells as seen in other cell types (Labuschagne et al., 2014; Maddocks et al., 2013) . Our data also indicate that the methionine and THF cycles are uncoupled in Teff cells, raising the possibility that epigenetic events regulated by SAM, a product of methionine metabolism, are influenced by metabolites other than glucose and serine in T cells. Expansion of sufficient numbers of antigen-specific CD8 + T cells is a key requirement for protective immunity against invading pathogens (Schmidt et al., 2010) . Strikingly, we found that reducing serum serine and glycine levels through dietary intervention dramatically reduced pathogen-driven T cell expansion, indicating a critical requirement for these non-essential amino acids in T cell responses in vivo. Interestingly, limiting serine availability during primary immunization was sufficient to impact secondary T cell responses, as demonstrated by impaired pathogen clearance and numbers of responding memory T cells upon re-challenge. These data indicate that serine availability can function as a metabolic checkpoint for effective immunity during primary T cell responses in vivo. Future work will need to focus on understanding the role(s) for serine metabolism in T cell subsets and/or activation state (i.e., primary versus memory T cell responses). Recent work examining the relationship between cancer cells and tumor-infiltrating lymphocytes (TILs) suggests that competition for metabolic resources may play a large factor in anti-tumor immune responses. Highly glycolytic tumors can effectively outcompete TILs for available glucose , leading to glucose limitation and impaired cytokine production by TILs (Chang et al., 2015; Ho et al., 2015) . However, serum glucose concentrations are tightly maintained in higher organisms, even under fasting conditions, making glucose restriction in vivo unlikely except in poorly perfused locations such as the tumor microenvironment. In contrast, we show here that dietary restriction of serine and glycine had a significant impact on antigen-specific Teff cell expansion in vivo. Interestingly, serine restriction has been shown to slow cancer progression in tumor-bearing mice (Maddocks et al., 2013) , although these experiments were conducted in mouse strains lacking adaptive immunity. Our observations suggest that serine availability in vivo may have important therapeutic implications for immunotherapy and anti-tumor T cell responses.
EXPERIMENTAL PROCEDURES
Mice C57BL/6 (CD45.1 and CD45.2) and OT-I mice were purchased from Charles River and Jackson Laboratories, respectively. For serine-restriction experiments, animals were fed Baker Purified Amino Acid Diet containing all essential amino acids plus serine, glycine, glutamine, arginine, cysteine, and tyrosine, or a test diet lacking serine and glycine, as previously published (Maddocks et al., 2013) . Animals were maintained on each diet for 2 weeks prior to infection, and maintained on their respective diets until experimental endpoint unless otherwise stated. Mice were bred and maintained under specific pathogen-free conditions at McGill University under approved protocols.
Immune Cell Purification and Culture Mouse T cell isolation and activation were conducted as previously described (Blagih et al., 2015) . CD3 + T cells were cultured in T cell medium (TCM) containing custom IMDM (without serine, glycine, glucose, and glutamine) supplemented with 10% dialyzed FBS (Wisent), L-glutamine, penicillin-streptomycin (Invitrogen), 2-ME (Sigma-Aldrich), and glucose. L-serine (0.4 mM), L-glycine (0.4 mM), formic acid (formate, 0.5 mM), dNTPs (50 mM), and/or dual SHMT1/2 inhibitor RZ-2994 were added to cell culture media as indicated. T cells were stimulated with plate-bound anti-CD3ε (clone 2C11) and anti-CD28 (clone 37.51) antibodies (eBioscience) and 50 U/mL IL2 (PeproTech), and proliferation was measured by 3 [H]-thymidine incorporation (1 mCi/mL), violet proliferation dye dilution, or cell counts. For human T cell analysis, peripheral blood mononuclear cells (PBMCs) were isolated by standard density-gradient centrifugation protocols (Gubser et al., 2013) , and naive CD8 + T cells (CD62L + CD45RA + ) were isolated by fluorescence-activated cell sorting (FACS) after enrichment using magnetic CD8 + microbeads (Miltenyi). Purified human CD8 + T cells were activated using anti-CD3/CD28 loaded beads at a 2:1 bead-to-cell ratio. Human PBMCs were obtained from healthy volunteers under approved protocols. Cytokine production by murine bone marrow-derived dendritic cells (BMDCs) following LPS treatment (100 ng/mL) was measured by ELISA as described (Boukhaled et al., 2016) .
Immunoblotting and Quantitative Real-Time PCR For immunoblotting, cells were lysed in modified AMPK lysis buffer as previously described (Faubert et al., 2014) , and proteins were detected using primary antibodies to Phgdh (Thermo-Scientific), Psat (Protein-Tech), Shmt1 (Protein-Tech), or Shmt2 (Cell Signaling Technology). For mRNA analysis, total mRNA was isolated from T cells using QIAzol (Qiagen), and cDNA was synthesized from 100 ng total RNA using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). qPCR was performed using an AriaMX Realtime PCR system (Agilent Technologies). Primer pairs used in this study are listed in the Supplemental Experimental Procedures.
Flow Cytometry
Single-cell suspensions were surface stained with fluorescently conjugated Abs (listed in the Supplemental Experimental Procedures) or K b /OVA tetramer (MHC Tetramer Production facility, Baylor College of Medicine). Cell viability was assessed using the Fixable Dye eFluor 780 and 506 (eBioscience) following the manufacturer's protocol. Intracellular cytokine staining (ICS) for IFN-g and TNF-a was performed as previously described (Blagih et al., 2015) . Flow cytometry was performed on Gallios (Beckman Coulter), LSR II, and LSR Fortessa (BD Biosciences) cytometers, and analysis was performed using FlowJo software (Tree Star).
Metabolic Assays
T cell OCR and ECAR were measured using a Seahorse XF96 Extracellular Flux Analyzer following established protocols (Blagih et al., 2015; Chang et al., 2013) . Activated T cells were plated in poly-D-lysine-coated XF96 plates via centrifugation in XF media (non-buffered DMEM 1640 containing 25 mM glucose, 2 mM L-glutamine, and 1 mM sodium pyruvate). Glucose and glutamine consumption and lactate production were measured using a Bioprofile Analyzer (NOVA Biomedical), with data normalized to cell number.
Infection with L. monocytogenes Mice were immunized intravenously (i.v.) with recombinant attenuated LmOVA (2 3 10 6 CFU [colony-forming units]) as previously described Krawczyk et al., 2007 [257] [258] [259] [260] [261] [262] [263] [264] ) (for endogenous responses) or CD45.2 (for adoptive transfer experiments). For memory re-challenge experiments, mice were immunized with attenuated LmOVA, followed by re-challenge with a lethal dose of virulent LmOVA (10 6 CFU) 32 days after primary immunization.
Splenocytes were isolated 5 days post-re-challenge and analyzed as described above. CFUs were determined in the spleens and liver 3 days post-re-challenge with virulent LmOVA as previously described (Duong et al., 2014) .
GC-and LC-MS Analysis of Metabolites
GC-MS was performed on T cells using previously described methods (Blagih et al., 2015; Griss et al., 2015) . Briefly, 5 3 10 6 activated T cells were washed with PBS and re-cultured in TCM (lacking glucose and serine) containing 10% dialyzed FBS and uniformly labeled [ 13 C]-glucose or [ 13 C]-serine (Cambridge Isotope Laboratories) for up to 6 hr. Metabolites were extracted using ice cold 80% methanol, sonicated, and derivatized as tert-butyldimethylsilyl (TBDMS) esters using 70 mL N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide (MTBSTFA) (Faubert et al., 2014) . For light chromatography-mass spectrometry (LC-MS) experiments, T cells (10 7 ) were seeded in 6-well plates and cultured in TCM containing [ 13 C]-serine for 24 hr prior to metabolite extraction.
MID for cellular metabolites was determined using a custom algorithm developed at McGill University (McGuirk et al., 2013) . Metabolite abundance was expressed relative to the internal standard (D-myristic acid) and normalized to cell number. Additional protocol details are described in the Supplemental Experimental Procedures.
SHMT1 and SHMT2 Activity Assays
Full-length human cytosolic SHMT1 (residues 1-483 in Uniprot: P34896) or mitochondrial SHMT2 (residues 30-504 in Uniprot: P34897) with mitochondrial leader sequence deleted was expressed as N-terminal His 6 -tagged proteins and purified in E. coli using nickel capture followed by size-exclusion chromatography. SHMT activity was determined by measuring serine production from glycine and methylene tetrahydrofolate (CH 2 -THF) using mass spectroscopy as described in the Supplemental Experimental Procedures.
Statistical Analysis
Data are presented as mean ± SD for technical replicates, or mean ± SEM for biological replicates, and analyzed using unpaired Student's t test or one-way ANOVA. Statistical significance is indicated in all figures by the following annotations: *p < 0.05; **p < 0.001; ***p < 0.0001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, four figures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.cmet.2016.12.011.
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